0001437749-24-017719.txt : 20240520 0001437749-24-017719.hdr.sgml : 20240520 20240520190038 ACCESSION NUMBER: 0001437749-24-017719 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240520 FILED AS OF DATE: 20240520 DATE AS OF CHANGE: 20240520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ignelzi Troy A. CENTRAL INDEX KEY: 0001579829 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42001 FILM NUMBER: 24966459 MAIL ADDRESS: STREET 1: C/O ESPERION THERAPEUTICS, INC. STREET 2: 46701 COMMERCE CENTER DRIVE CITY: PLYMOUTH STATE: MI ZIP: 48170 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Contineum Therapeutics, Inc. CENTRAL INDEX KEY: 0001855175 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 271467257 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10578 SCIENCE CENTER DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 333-5280 MAIL ADDRESS: STREET 1: 10578 SCIENCE CENTER DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Pipeline Therapeutics, Inc. DATE OF NAME CHANGE: 20210405 4 1 rdgdoc.xml FORM 4 X0508 4 2024-05-20 0001855175 Contineum Therapeutics, Inc. CTNM 0001579829 Ignelzi Troy A. 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 1 0 Stock Option (right to buy) 15.71 2024-05-20 4 A 0 23150 0 A 2034-05-19 Class A Common Stock 23150 23150 D Options granted under the Issuer's 2024 Equity Incentive Plan, pursuant to the Issuer's Non-Employee Director Compensation Plan. One-third of the option shares vest and become exercisable on May 20, 2025, and the remainder vests in 24 equal monthly installments thereafter, subject to the Reporting Person's continuous service. /s/ Peter Slover, Attorney-in-Fact 2024-05-20